Autentificare
NeuroPsy InfoHubÎnțelege · Sprijin · ProgresCere sprijin

Informație de încredere. Sprijin real.

Ai întrebări despre autism, ADHD, anxietate sau depresie? Găsești ghiduri clare, verificate de specialiști. Acum, acces gratuit.

Începe gratuitSunt părinteSunt specialist
Spațiu publicitar disponibil — bannerul mare de susSpațiu publicitar disponibil — bannerul mare de sus

Explorează temele

Caută tot →

Sănătate mintală și neurodezvoltare

AutismSpectrul autist și particularitățile asociate.496 de articole
ADHDAtenție, impulsivitate și hiperactivitate.396 de articole
Sindrom DownDezvoltare și sprijin pentru sindromul Down.330 de articole
AnxietateÎngrijorare excesivă, tensiune, atacuri de panică.75 de articole
DepresieTristețe persistentă, lipsa energiei și a motivației.110 articole
AdicțiiDependențe de substanțe și comportamentale.137 de articole

Afecțiuni neurologice

DemențeBoala Alzheimer și alte forme de demență.74 de articole
AVC și AITAccident vascular cerebral și recuperare, la orice vârstă.67 de articole
Leziuni medulareLeziuni medulare, paraplegie și tetraplegie.59 de articole
EpilepsieCrize epileptice și managementul lor.128 de articole
ParkinsonBoala Parkinson și tulburări de mișcare.65 de articole
Scleroză multiplăScleroza multiplă și viața cu aceasta.72 de articole
Traumatisme cranio-cerebraleTraumatisme cranio-cerebrale și recuperare.88 de articole

Articole și ghiduri recomandate

PublicToțiPentru oricineSpecialiști
VârstăToate vârsteleCopiiTineriAdulțiVârstnici
StudiuParkinsonÎncredere înaltă20.06.2026

Prodromal Peripheral Immune Cell Profile in Drug-Induced Parkinsonism Relative to Parkinson's Disease

This study compared immune cell profiles in individuals with drug-induced Parkinsonism (DIP) and idiopathic Parkinson's disease (PD) using UK Biobank data, finding that both conditions showed elevated neutrophil counts and immune inflammation markers approximately 9 years before diagnosis. However, immune alterations in DIP were attributable to psychiatric comorbidities, while reduced lymphocyte counts appeared to be a distinctive prodromal biomarker specific to PD.

StudiuParkinsonÎncredere înaltă20.06.2026

Fecal Tyrosine Decarboxylase and Motor Response Complications in Parkinson's Disease

This study examined whether gut bacterial tyrosine decarboxylase (TDC), which metabolizes levodopa, is associated with motor complications in 178 Parkinson's disease patients. While patients with dyskinesia and motor fluctuations showed 2-3 fold higher fecal TDC levels, differences were not statistically significant, suggesting a potential but unproven relationship between microbiota-derived enzymes and treatment response variability.

StudiuParkinsonÎncredere înaltă20.06.2026

Wearable Sensor-Based Gait Measures as Objective Indicators of Parkinson's Disease Severity: A Systematic Review and Meta-Analysis

This systematic review of 93 studies examined whether inertial measurement units (IMUs) can accurately quantify Parkinson's disease motor severity by correlating gait parameters with established clinical scales (MDS-UPDRS III, Hoehn and Yahr). Meta-analysis findings confirm that objective gait metrics including reduced velocity, shorter step length, prolonged stance time, and decreased turning speed reliably reflect disease severity and progression stages.

StudiuParkinsonÎncredere bună19.06.2026

Cumulative Head Trauma from Soccer and Traumatic Brain Injury Associated with Parkinson's Disease Risk in Former Athletes

This cross-sectional study of 1,231 participants from the Fox Insight cohort examined whether repetitive head impacts from soccer and traumatic brain injury (TBI) history independently or cumulatively increase Parkinson's disease (PD) risk. Former soccer players with a history of TBI with loss of consciousness showed significantly elevated odds of PD diagnosis compared to those without such cumulative exposure.

StudiuParkinsonÎncredere înaltă19.06.2026

Amyloid Status as a Moderator of Physical Activity's Effect on Parkinson's Disease Progression

This longitudinal study examined whether amyloid copathology modifies how physical activity influences Parkinson's disease progression in 245 patients followed over 4+ years. Results showed amyloid positivity significantly moderated physical activity's effects on motor severity, with amyloid-negative patients showing slower biomarker increases (neurofilament light chain and tau) associated with higher physical activity levels.